Thomas D. Reed, Chief Science Officer at INTREXON CORP (XON), sold 30,000 shares at $6.36 ($191K) on 2018-12-31, disclosed to the SEC on 2019-01-03.
Open-market sale of $191k XON by Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| XON | SELL | 2020-01-03 | $20K | — | Filing → |
| XON | SELL | 2019-10-02 | $20K | — | Filing → |
| XON | SELL | 2019-07-02 | $27K | — | Filing → |